Thank you very much.
As you mentioned, similar to CETA the IP chapter of the TPP could cause an increase in the cost of pharmaceutical drugs. Is this true? Is there a study done in the context of the TPP to investigate the impact of the IP chapter on the cost of drugs in Canada?